Platelet aggregation is a fundamental biological phenomenon critical for the maintenance of vascular health and the prevention of excessive bleeding. This intricate process involves the binding of platelets to exposed collagen at the site of vascular injury, initiating a series of events that culminate in the formation of a blood clot. The activated platelets release chemical signals, recruiting and activating additional platelets to amplify the response. This orchestrated cascade of platelet activation is pivotal for hemostasis, ensuring the swift formation of a protective clot to seal any breaches in blood vessels. The plug formed by aggregated platelets is indispensable for preventing prolonged bleeding and facilitating wound healing. However, deviations from the finely tuned regulation of platelet aggregation can lead to detrimental outcomes, such as thrombosis, where excessive clotting occurs within blood vessels.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation